BCM
PFE icon

Buckhead Capital Management’s Pfizer PFE Stock Holding History

Buckhead Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-53,629
Closed -$1.54M – 123
2023
Q4 		$1.54M Sell
53,629
-3,221
-6% -$97.4K 0.57% 54
2023
Q3 		$1.89M Sell
56,850
-111,709
-66% -$3.95M 0.78% 46
2023
Q2 		$6.18M Sell
168,559
-447
-0.3% -$17.4K 1.47% 23
2023
Q1 		$6.9M Buy
169,006
+1,158
+0.7% +$50K 1.62% 18
2022
Q4 		$8.6M Buy
167,848
+2,140
+1% +$103K 2.08% 14
2022
Q3 		$7.25M Sell
165,708
-7,572
-4% -$368K 1.88% 16
2022
Q2 		$9.09M Buy
173,280
+909
+0.5% +$46.3K 2.25% 9
2022
Q1 		$8.92M Sell
172,371
-818
-0.5% -$42.4K 1.93% 17
2021
Q4 		$10.2M Buy
173,189
+1,276
+0.7% +$63.2K 2.16% 9
2021
Q3 		$7.39M Buy
171,913
+1,268
+0.7% +$56.2K 1.65% 19
2021
Q2 		$6.68M Buy
170,645
+22
+0% +$856 1.48% 23
2021
Q1 		$6.18M Sell
170,623
-38
-0% -$1.35K 1.44% 28
2020
Q4 		$6.28M Sell
170,661
-115,087
-40% -$4.22M 1.56% 25
2020
Q3 		$9.95M Buy
285,748
+504
+0.2% +$17.7K 2.84% 7
2020
Q2 		$8.85M Buy
285,244
+6,535
+2% +$222K 2.7% 10
2020
Q1 		$8.63M Buy
278,709
+25,588
+10% +$872K 3.22% 8
2019
Q4 		$9.41M Sell
253,121
-3,633
-1% -$129K 2.66% 10
2019
Q3 		$8.75M Buy
256,754
+20,778
+9% +$756K 2.51% 11
2019
Q2 		$9.7M Sell
235,976
-511
-0.2% -$20.3K 2.91% 6
2019
Q1 		$9.53M Buy
236,487
+1,028
+0.4% +$41.2K 2.97% 5
2018
Q4 		$9.75M Buy
235,459
+477
+0.2% +$19.8K 3.42% 2
2018
Q3 		$9.82M Sell
234,982
-2,586
-1% -$99.6K 3.01% 3
2018
Q2 		$8.18M Buy
237,568
+816
+0.3% +$27.9K 2.7% 8
2018
Q1 		$7.97M Sell
236,752
-10,482
-4% -$360K 1.76% 13
2017
Q4 		$8.5M Sell
247,234
-23,028
-9% -$785K 1.81% 10
2017
Q3 		$9.15M Sell
270,262
-62,079
-19% -$2M 1.97% 4
2017
Q2 		$10.6M Sell
332,341
-4,708
-1% -$148K 1.92% 8
2017
Q1 		$10.9M Sell
337,049
-975
-0.3% -$30.7K 2.01% 8
2016
Q4 		$10.4M Sell
338,024
-6,345
-2% -$194K 1.98% 7
2016
Q3 		$11.1M Sell
344,369
-8,293
-2% -$277K 2.11% 6
2016
Q2 		$11.8M Buy
352,662
+20,085
+6% +$641K 2.14% 5
2016
Q1 		$9.35M Sell
332,577
-1,318
-0.4% -$37.6K 1.74% 9
2015
Q4 		$10.2M Sell
333,895
-2,237
-0.7% -$70.4K 1.89% 8
2015
Q3 		$10M Sell
336,132
-4,617
-1% -$148K 1.96% 6
2015
Q2 		$10.8M Sell
340,749
-13,084
-4% -$426K 1.98% 7
2015
Q1 		$11.7M Sell
353,833
-19,155
-5% -$609K 2.07% 5
2014
Q4 		$11M Sell
372,988
-31,557
-8% -$905K 1.94% 6
2014
Q3 		$11.3M Sell
404,545
-76,688
-16% -$2.15M 1.97% 6
2014
Q2 		$13.6M Sell
481,233
-30,246
-6% -$862K 1.92% 4
2014
Q1 		$15.6M Sell
511,479
-14,434
-3% -$430K 1.98% 2
2013
Q4 		$15.3M Sell
525,913
-24,336
-4% -$708K 1.99% 3
2013
Q3 		$15M Sell
550,249
-24,953
-4% -$679K 2.06% 3
2013
Q2 		$15.3M Buy
+575,202
New +$15.9M 1.93% 3

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Buckhead Capital Management's PFE Position: Q1 2024 in Review

Buckhead Capital Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 53,629 shares — an estimated $1.54M sold.

Buckhead Capital Management first reported a position in PFE in Q2 2013 and held it in 43 quarters. The position peaked at $15.6M in Q1 2014. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Buckhead Capital Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
  • Buckhead Capital Management sold 53,629 Pfizer shares in Q1 2024, an estimated $1.54M.
  • Buckhead Capital Management first reported a position in Pfizer in Q2 2013 and held it in 43 quarters.
  • Buckhead Capital Management's Pfizer position peaked at $15.6M in Q1 2014.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Buckhead Capital Management's 13F filing for Q1 2024, filed 6 May 2024.